134 related articles for article (PubMed ID: 25999443)
1. B7-H3 ameliorates GVHD.
Steinberger P
Blood; 2015 May; 125(21):3219-21. PubMed ID: 25999443
[No Abstract] [Full Text] [Related]
2. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality.
Veenstra RG; Flynn R; Kreymborg K; McDonald-Hyman C; Saha A; Taylor PA; Osborn MJ; Panoskaltsis-Mortari A; Schmitt-Graeff A; Lieberknecht E; Murphy WJ; Serody JS; Munn DH; Freeman GJ; Allison JP; Mak TW; van den Brink M; Zeiser R; Blazar BR
Blood; 2015 May; 125(21):3335-46. PubMed ID: 25814530
[TBL] [Abstract][Full Text] [Related]
3. [Hypereosinophilia after allogeneic bone marrow transplantation. A possible role of IL-5 overproduction by donor T-cells chronic GVHD].
Masumoto A; Sasao T; Yoshiba F; Kato S; Mori A; Okudaira H; Hotta T
Rinsho Ketsueki; 1997 Mar; 38(3):234-6. PubMed ID: 9095665
[TBL] [Abstract][Full Text] [Related]
4. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
[TBL] [Abstract][Full Text] [Related]
5. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
[TBL] [Abstract][Full Text] [Related]
6. [Acute GVHD: pathogenesis, symptomatology, stage/severity, and treatment].
Imamura M; Miyazaki T; Kasai M
Nihon Rinsho; 1990 Sep; 48(9):2055-60. PubMed ID: 2232210
[No Abstract] [Full Text] [Related]
7. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
[TBL] [Abstract][Full Text] [Related]
8. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
Blazar BR; Sharpe AH; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Korngold R; Vallera DA
J Immunol; 1996 Oct; 157(8):3250-9. PubMed ID: 8871619
[TBL] [Abstract][Full Text] [Related]
9. Cytokine dysregulation as a mechanism of graft versus host disease.
Ferrara JL
Curr Opin Immunol; 1993 Oct; 5(5):794-9. PubMed ID: 8240742
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-host disease: an alternative hypothesis.
Parkman R
Immunol Today; 1989 Nov; 10(11):362-4. PubMed ID: 2692593
[TBL] [Abstract][Full Text] [Related]
11. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
[TBL] [Abstract][Full Text] [Related]
12. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
Champlin R
Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of graft-versus-host disease. Use of a T cell-controlled suicide gene.
Helene M; Lake-Bullock V; Bryson JS; Jennings CD; Kaplan AM
J Immunol; 1997 Jun; 158(11):5079-82. PubMed ID: 9164920
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and bone marrow transplantation.
Hill GR
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):139-41. PubMed ID: 19147094
[TBL] [Abstract][Full Text] [Related]
15. A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation.
Sviland L; Dickinson AM
J Clin Pathol; 1999 Dec; 52(12):910-3. PubMed ID: 10711254
[TBL] [Abstract][Full Text] [Related]
16. Allorecognition and graft-versus-host disease.
Theobald M
Bone Marrow Transplant; 1995 Apr; 15(4):489-98. PubMed ID: 7655371
[TBL] [Abstract][Full Text] [Related]
17. Haploidentical bone marrow transplantation in primary immune deficiency: stem cell selection and manipulation.
Hagin D; Reisner Y
Immunol Allergy Clin North Am; 2010 Feb; 30(1):45-62. PubMed ID: 20113886
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
[TBL] [Abstract][Full Text] [Related]
19. Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats.
Weijtens M; van Spronsen A; Hagenbeek A; Braakman E; Martens A
Hum Gene Ther; 2002 Jan; 13(2):187-98. PubMed ID: 11812276
[TBL] [Abstract][Full Text] [Related]
20. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.
Annat J; Churaqui E; Dutartre P; Bruley-Rosset M
Transplantation; 1996 Sep; 62(6):721-9. PubMed ID: 8824467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
